|
HY-108507-10mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-25mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-5mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-50mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-1mL
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-145918-10mg
|
MedChemexpress LLC
|
MRT-14 [CAS 1263131-83-4]
|
|
Cancer-programmed cell death
|
|
|
HY-145918-100mg
|
MedChemexpress LLC
|
MRT-14 [CAS 1263131-83-4]
|
|
Cancer-programmed cell death
|
|
|
HY-145918-5mg
|
MedChemexpress LLC
|
MRT-14 [CAS 1263131-83-4]
|
|
Cancer-programmed cell death
|
|
|
HY-145918-50mg
|
MedChemexpress LLC
|
MRT-14 [CAS 1263131-83-4]
|
|
Cancer-programmed cell death
|
|
|
HY-120877-10mg
|
MedChemexpress LLC
|
MRT199665 [CAS 1456858-57-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-120877-25mg
|
MedChemexpress LLC
|
MRT199665 [CAS 1456858-57-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-120877-5mg
|
MedChemexpress LLC
|
MRT199665 [CAS 1456858-57-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-120877-50mg
|
MedChemexpress LLC
|
MRT199665 [CAS 1456858-57-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-120877-1mL
|
MedChemexpress LLC
|
MRT199665 [CAS 1456858-57-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-153356-10mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153356-100mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153356-5mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153356-50mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-13018-10mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-100mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-5mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-50mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-1mL
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-100006A-1mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-10mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
